In line with previous findings, our present analysis of MAF profiles involving a large cohort of cutaneous malignant melanomas has confirmed that primary and visceral metastatic melanomas are both extremely heterogeneous for oncogenic drivers BRAF and NRAS, and this is neither due to technical issues nor to tumor-to-normal cell ratios [19]. This evidence concerns the gene NRAS and metastatic melanoma.